BG29724A3 - Method for obtaining of cristal- alfa- from of prazocin hydrochloride - Google Patents

Method for obtaining of cristal- alfa- from of prazocin hydrochloride

Info

Publication number: BG29724A3
Authority: BG; Bulgaria
Prior art keywords: cristal; alfa; obtaining; hydrochloride; prazocin
Prior art date: 1976-03-01

Application number

BG035558A

Other languages

Bulgarian (bg)

English (en)

Inventor

Ernest Bianco

Original Assignee

Неизвестен

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-03-01

Filing date

1977-03-01

Publication date

1981-01-15

1977-03-01 Application filed by Неизвестен filed Critical Неизвестен

1981-01-15 Publication of BG29724A3 publication Critical patent/BG29724A3/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BG035558A 1976-03-01 1977-03-01 Method for obtaining of cristal- alfa- from of prazocin hydrochloride BG29724A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/662,937 US4092315A (en)	1976-03-01	1976-03-01	Novel crystalline forms of prazosin hydrochloride

Publications (1)

Publication Number	Publication Date
BG29724A3 true BG29724A3 (en)	1981-01-15

Family

ID=24659839

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG035558A BG29724A3 (en)	1976-03-01	1977-03-01	Method for obtaining of cristal- alfa- from of prazocin hydrochloride

Country Status (32)

Country	Link
US (1)	US4092315A (sv)
JP (1)	JPS604188B2 (sv)
AR (1)	AR210937A1 (sv)
AU (1)	AU506937B2 (sv)
BE (1)	BE851878A (sv)
BG (1)	BG29724A3 (sv)
CA (1)	CA1068269A (sv)
CH (1)	CH618436A5 (sv)
CS (1)	CS191332B2 (sv)
DD (1)	DD129652A5 (sv)
DE (1)	DE2708192C3 (sv)
DK (1)	DK145858C (sv)
ES (1)	ES8707447A1 (sv)
FI (1)	FI62082C (sv)
FR (1)	FR2372828A1 (sv)
GB (1)	GB1538713A (sv)
HK (1)	HK30881A (sv)
HU (1)	HU173641B (sv)
IE (1)	IE44522B1 (sv)
IL (1)	IL51481A (sv)
LU (1)	LU76868A1 (sv)
MY (1)	MY8100271A (sv)
NL (1)	NL169591C (sv)
NO (1)	NO146499C (sv)
NZ (1)	NZ183450A (sv)
PL (1)	PL105559B1 (sv)
PT (1)	PT66227B (sv)
RO (1)	RO73095A (sv)
SE (1)	SE423234B (sv)
SU (1)	SU644387A3 (sv)
YU (1)	YU41294B (sv)
ZA (1)	ZA77918B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX5483E (es) *	1977-08-04	1983-08-23	Abbott Lab	Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
GB1591490A (en) *	1977-08-04	1981-06-24	Abbott Lab	1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4197301A (en) *	1978-10-16	1980-04-08	Allergan Pharmaceuticals, Inc.	Topical ophthalmic use of Prazosin
FI67699C (fi) *	1979-01-31	1985-05-10	Orion Yhtymae Oy	Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) *	1983-02-11	1984-04-03	Abbott Laboratories	2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (sv) *	1984-06-25	1989-11-10	Orion Yhtymae Oy	Förfarande för framställning av stabil -form av prazosinhydroklorid.
US5322943A (en) *	1985-09-12	1994-06-21	The Upjohn Company	Piperazine compounds which are substituted
US4601897A (en) *	1985-11-06	1986-07-22	Pfizer Inc.	Prazosin-pirbuterol combination for bronchodilation
DE3683760D1 (de) *	1986-03-21	1992-03-12	Heumann Pharma Gmbh & Co	Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5110927A (en) *	1987-12-31	1992-05-05	The United States Of America As Represented By The Department Of Health And Human Services	Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) *	1990-12-31	1997-09-10	住化ファインケム株式会社	１−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
US5952003A (en) *	1996-08-01	1999-09-14	Novartis Corporation	Terazosin capsules
EP0849264A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849266B8 (de) *	1996-12-20	2007-10-03	Heumann PCS GmbH	Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849265A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP3172377B1 (en)	2014-07-21	2018-09-12	KEIR Manufacturing, Inc.	Aerodynamic flyer bow

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3663706A (en) *	1969-09-29	1972-05-16	Pfizer	Use of 2,4-diaminoquinazolines as hypotensive agents

1976
- 1976-03-01 US US05/662,937 patent/US4092315A/en not_active Expired - Lifetime
1977
- 1977-02-11 GB GB5756/77A patent/GB1538713A/en not_active Expired
- 1977-02-14 SE SE7701624A patent/SE423234B/sv not_active IP Right Cessation
- 1977-02-16 ZA ZA770918A patent/ZA77918B/xx unknown
- 1977-02-17 IL IL51481A patent/IL51481A/xx unknown
- 1977-02-18 CA CA272,080A patent/CA1068269A/en not_active Expired
- 1977-02-18 AU AU22443/77A patent/AU506937B2/en not_active Expired
- 1977-02-23 YU YU499/77A patent/YU41294B/xx unknown
- 1977-02-24 IE IE399/77A patent/IE44522B1/en not_active IP Right Cessation
- 1977-02-24 PT PT66227A patent/PT66227B/pt unknown
- 1977-02-25 DE DE2708192A patent/DE2708192C3/de not_active Expired
- 1977-02-28 SU SU772457100A patent/SU644387A3/ru active
- 1977-02-28 BE BE1007976A patent/BE851878A/xx not_active IP Right Cessation
- 1977-02-28 JP JP52021433A patent/JPS604188B2/ja not_active Expired
- 1977-02-28 FI FI770634A patent/FI62082C/fi not_active IP Right Cessation
- 1977-02-28 FR FR7705819A patent/FR2372828A1/fr active Granted
- 1977-02-28 DK DK86877A patent/DK145858C/da not_active IP Right Cessation
- 1977-02-28 NZ NZ183450A patent/NZ183450A/xx unknown
- 1977-02-28 NO NO770674A patent/NO146499C/no unknown
- 1977-02-28 HU HU76UO128A patent/HU173641B/hu unknown
- 1977-02-28 ES ES545368A patent/ES8707447A1/es not_active Expired
- 1977-02-28 NL NLAANVRAGE7702123,A patent/NL169591C/xx not_active IP Right Cessation
- 1977-03-01 PL PL1977196354A patent/PL105559B1/pl not_active IP Right Cessation
- 1977-03-01 RO RO7789566A patent/RO73095A/ro unknown
- 1977-03-01 DD DD7700197618A patent/DD129652A5/xx unknown
- 1977-03-01 CH CH255577A patent/CH618436A5/fr not_active IP Right Cessation
- 1977-03-01 CS CS771358A patent/CS191332B2/cs unknown
- 1977-03-01 BG BG035558A patent/BG29724A3/xx unknown
- 1977-03-01 AR AR266724A patent/AR210937A1/es active
- 1977-03-01 LU LU76868A patent/LU76868A1/xx unknown
1981
- 1981-07-02 HK HK308/81A patent/HK30881A/xx unknown
- 1981-12-30 MY MY271/81A patent/MY8100271A/xx unknown

Also Published As

Publication number	Publication date
HU173641B (en)	1979-07-28
CH618436A5 (sv)	1980-07-31
BE851878A (fr)	1977-08-29
IL51481A0 (en)	1977-04-29
DE2708192B2 (de)	1979-08-02
FI62082B (fi)	1982-07-30
NL169591B (nl)	1982-03-01
FI770634A (sv)	1977-09-02
YU41294B (en)	1987-02-28
DE2708192A1 (de)	1977-09-08
FR2372828A1 (fr)	1978-06-30
DK145858C (da)	1983-09-12
NZ183450A (en)	1979-03-16
CS191332B2 (en)	1979-06-29
JPS604188B2 (ja)	1985-02-01
NO770674L (no)	1977-09-02
CA1068269A (en)	1979-12-18
PL196354A1 (pl)	1978-02-27
FI62082C (fi)	1982-11-10
ES8707447A1 (es)	1987-08-16
SE7701624L (sv)	1977-09-02
DK145858B (da)	1983-03-21
PL105559B1 (pl)	1979-10-31
SU644387A3 (ru)	1979-01-25
NO146499C (no)	1982-10-13
GB1538713A (en)	1979-01-24
NL169591C (nl)	1982-08-02
DK86877A (da)	1977-09-02
HK30881A (en)	1981-07-10
PT66227B (en)	1978-07-14
FR2372828B1 (sv)	1980-02-01
ZA77918B (en)	1977-12-28
ES545368A0 (es)	1978-06-01
DE2708192C3 (de)	1980-05-08
DD129652A5 (de)	1978-02-01
JPS52105206A (en)	1977-09-03
AU2244377A (en)	1978-11-23
NL7702123A (nl)	1977-09-05
RO73095A (ro)	1981-06-26
LU76868A1 (sv)	1977-09-21
US4092315A (en)	1978-05-30
IE44522B1 (en)	1981-12-30
AR210937A1 (es)	1977-09-30
MY8100271A (en)	1981-12-31
PT66227A (en)	1977-03-01
YU49977A (en)	1983-12-31
IL51481A (en)	1980-09-16
IE44522L (en)	1977-09-01
SE423234B (sv)	1982-04-26
NO146499B (no)	1982-07-05
AU506937B2 (en)	1980-01-31

Publication	Publication Date	Title
BG34336A3 (en)	1983-08-15	Method for obtaining derivates of phtalazine-4-yl-acetic acid
BG28061A3 (en)	1980-02-25	Method of obtaining of hexahydrodibenzopyranones
BG29724A3 (en)	1981-01-15	Method for obtaining of cristal- alfa- from of prazocin hydrochloride
BG37075A3 (en)	1985-03-15	Method for preparing derivatives of proline
BG32851A3 (en)	1982-10-15	Method for obtaining of 3, 4, 5, 6- tetrahydro- 2 h- 1- benzoxycin
BG33006A3 (en)	1982-11-15	Method for obtaining of n- (perfluoracil)- n- phosphonomethyl- glycine compounds
BG33585A3 (bg)	1983-03-15	Нов метод за получаване на азини
BG28068A3 (en)	1980-02-25	Method of obtaining of 3-chlorcephalosporines
BG34185A3 (en)	1983-07-15	Method for obtaining pepperazinilpyrazine derivative
BG35746A3 (en)	1984-06-15	Method for preparing 1- cyclohexenylmethylpyrolidines
BG34036A3 (en)	1983-06-15	A method of obtaining propargyl- 2- phenylamino- imidazolines- (2) and their acid salts
BG28054A3 (en)	1980-02-25	Method of obtaining of 2-(4-aroylpiperazine-1-il)-4- amino-6,7-dimetoxyhinazoline
BG28064A3 (en)	1980-02-25	Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG33292A3 (en)	1983-01-14	Method for obtaining of penamsulphooxide derivatives
BG32849A3 (en)	1982-10-15	Method for obtaining of 2- chlor- 4- substituated derivatives of thiazolcarbonic acids
BG35594A3 (en)	1984-05-15	Method for preparing of 2-[4-(2-furoyl)- piperazine-1- yl)- 4- amino-6,7- dimetoxyquinazoline
BG33435A3 (en)	1983-02-15	Method for obtaining of 6- methyl- 8- (substituated) methylergoline
BG28055A3 (en)	1980-02-25	Method of obtaining of phenylperazine derivatives
BG41129A3 (en)	1987-04-15	Method for preparing acetamide derivatives
BG35031A3 (en)	1984-01-16	Method for preparing 1, 1, 2- triphenyl- propane (propene) derivatives
BG30926A3 (en)	1981-09-15	Method for obtaining of n- /1- methyl- 2- pyrolidinil- methyl- 2, 3- dimethoxy- 5- methylsulphamoilbenzamid and its derivatives
BG27893A3 (en)	1980-01-15	Method of obtaining of benzyl esters
BG33436A3 (en)	1983-02-15	Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
BG28564A4 (en)	1980-05-15	- 3- cyclohexen- 1- ona
BG30918A3 (en)	1981-09-15	Method for obtaining of substituated 5h- dibenz ( b, f )- azerine